Skip to content

Effect of Two Exercise Programs on Bone Strength and Architecture

Effect of Two Exercise Programs on Bone Strength and Architecture

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02636530
Enrollment
48
Registered
2015-12-21
Start date
2016-07-01
Completion date
2021-12-01
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Brief summary

Bone responds according to the load placed on it. In this study, investigators want to know if exercise that loads the body in exercises, like walking or jogging (Ground Reaction Forces: GRF), affects bone differently than exercises that load the joints, like weight lifting (Joint Reaction Forces: JRF). Participants will exercise at least 3 times a week for 6 months. Measures of bone strength and mass, muscular strength, and aerobic fitness will be taken at the beginning and the end of the 6 month program. Period blood samples will be taken for future analysis of blood markers.

Interventions

BEHAVIORALGround Reaction Forces

6 month exercise program that loads the body via gravitational forces.

BEHAVIORALJoint Reaction Forces

6 month exercise program that loads the body via loading the joints.

Sponsors

VA Eastern Colorado Health Care System
CollaboratorFED
University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* non-smoker * in generally good health * not physically active (less than 60 minutes of purposeful exercise/week) * able to travel to the exercise facility a minimum of 3 times/week

Exclusion criteria

* use of glucocorticoids * abnormal resting EKG * angina and/or evidence of acute myocardial ischemia during a treadmill test * resting blood pressure above 150 mmHg systolic of 90 mmHg diastolic * anti-resorptive drug use in the last 2 years * initiation of treatments that could impact bone metabolism (diuretics, hormones, bine anabolic agents) in the prior 6 months * dual-energy x-ray absorptiometry (DXA) t-score \<+ -2.5 at the femoral neck and/or lumbar spine * serum vitamin D concentration \<20 ng/mL * uncontrolled thyroid disease * any contraindications to regular exercise

Design outcomes

Primary

MeasureTime frameDescription
Change in Volumetric Bone Mineral Density (vBMD)Baseline and 6 monthMeasured via quantitative computed tomography (QCT)
Change in Areal Bone Mineral Density (aBMD)Baseline and 6 monthMeasured via dual-energy x-ray absorptiometry (DXA)
Change in Bone StrengthBaseline and 6 monthMeasured via finite element analysis (FEA) from QCT

Secondary

MeasureTime frame
Change in 1-Repetition Maximum (1RM)Baseline and 6 month
Change in Maximal Oxygen Uptake (cardiovascular fitness)Baseline and 6 month

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026